>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

May 20, 2013

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility: Recall - Lack Of Sterility Assurance

Summary:

All Sterile Drug Products Made and Distributed By NuVision Pharmacy Dallas Facility

May 14, 2013

Zolpidem Containing Products: Drug Safety Communication - FDA Requires Lower Recommended Doses

Summary:

Zolpidem Containing Products Drug Safety Communication

May 09, 2013

The Compounding Shop: FDA News Release - Lack of Sterility Assurance of Drug Products

Summary:

The Compounding Shop FDA News Release Lack of Sterility

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Anesthesiology Continuing Education (ACE) Program

SKU: 30702-13CE

... Read more »

Single Copies, Member Price: $360

ASA Submits Letter to CMS on Hospital Interpretive Guidelines

January 18, 2010

ASA Submits Letter to CMS on Hospital Interpretive Guidelines

ASA, under the leadership of President Alex Hannenberg, M.D., submitted a letter to the Centers for Medicare and Medicaid Services (CMS) today stating ASA’s perspective and concerns in regards to the December 11, 2009 revisions to the hospital interpretive guidelines that impact anesthesia services.  For a link to the interpretive guidelines,
click here.

ASA’s Letter to CMS on Hospital Interpretive Guidelines